CITATION — REFERENCE ENTRY

low-dose-colchicine · fitzgerald-2020-acr-gout-guideline

Revision 77fa991b-b2b1-495f-a50d-15b38a1c6711 · 9/26/2026, 8:24:00 PM UTC

Citation: fitzgerald-2020-acr-gout-guideline
Claim ID: low-dose-colchicine
Assertion: When colchicine is used for a flare, low-dose colchicine is strongly recommended over high-dose because efficacy is similar and adverse effects are fewer.
Quote: Given similar efficacy and a lower risk of adverse effects, low-dose colchicine over high-dose colchicine is strongly recommended when colchicine is the chosen agent.
Quote language: en
Locator: section: Gout flare management

Available in